ECS Stock Overview
Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ECS Botanics Holdings Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.011 |
| 52 Week High | AU$0.022 |
| 52 Week Low | AU$0.01 |
| Beta | 0.94 |
| 1 Month Change | -15.38% |
| 3 Month Change | -31.25% |
| 1 Year Change | -47.62% |
| 3 Year Change | -60.00% |
| 5 Year Change | -66.67% |
| Change since IPO | -83.08% |
Recent News & Updates
ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Industry But So Is The Business
Mar 11
Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop
Nov 11There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise
Sep 27Recent updates
ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Industry But So Is The Business
Mar 11Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop
Nov 11There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise
Sep 27ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business
Aug 12There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding
Apr 03ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk
Sep 06ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans
Feb 24Shareholder Returns
| ECS | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | 8.2% | 3.5% |
| 1Y | -47.6% | -24.7% | 0.09% |
Return vs Industry: ECS underperformed the Australian Pharmaceuticals industry which returned -24.7% over the past year.
Return vs Market: ECS underperformed the Australian Market which returned 0.1% over the past year.
Price Volatility
| ECS volatility | |
|---|---|
| ECS Average Weekly Movement | 10.5% |
| Pharmaceuticals Industry Average Movement | 11.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in AU Market | 16.6% |
| 10% least volatile stocks in AU Market | 4.0% |
Stable Share Price: ECS has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: ECS's weekly volatility (10%) has been stable over the past year.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Nan-Maree Schoerie | www.ecs-botanics.com |
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. The company is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.
ECS Botanics Holdings Ltd Fundamentals Summary
| ECS fundamental statistics | |
|---|---|
| Market cap | AU$14.26m |
| Earnings (TTM) | -AU$1.31m |
| Revenue (TTM) | AU$18.48m |
0.8x
P/S Ratio-10.9x
P/E RatioIs ECS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ECS income statement (TTM) | |
|---|---|
| Revenue | AU$18.48m |
| Cost of Revenue | AU$12.70m |
| Gross Profit | AU$5.78m |
| Other Expenses | AU$7.09m |
| Earnings | -AU$1.31m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.001 |
| Gross Margin | 31.26% |
| Net Profit Margin | -7.11% |
| Debt/Equity Ratio | 5.2% |
How did ECS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/16 12:08 |
| End of Day Share Price | 2025/04/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ECS Botanics Holdings Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stuart Roberts | Pitt Street Research Pty Ltd. |